Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
As of today, Amgen(AMGN) shares are valued at $342.36. The company's market cap stands at 186.05B, with a P/E ratio of 26.64 and a dividend yield of 2.7%.
On 2025-11-29, Amgen(AMGN) stock moved within a range of $342.29 to $346.00. With shares now at $342.36, the stock is trading +0.0% above its intraday low and -1.1% below the session's peak.
Trading activity shows a volume of 1.27M, compared to an average daily volume of 2.87M.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $346.00 and a low of $253.30.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $346.00 and a low of $253.30.
AMGN News
Amgen (AMGN) just secured full approval from the FDA for IMDELLTRA, its new therapy for adults with advanced small cell lung cancer that has progressed after pl...
Amgen recently announced that the FDA granted full approval to IMDELLTRA (tarlatamab-dlle) for adults with extensive stage small cell lung cancer (ES-SCLC) whos...
Tuesday, November 25, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research repor...
Analyst ratings
45%
of 33 ratingsMore AMGN News
Truist assumed coverage of Amgen (AMGN) with a Hold rating with a price target of $318, up from $298. The firm views the stock as a defensive biotech with a sta...
Insiders have been trading these 5 stocks: ((TEVA)), ((AMGN)), ((RITM)), ((FSLY)) and ((MDT)). Here is a breakdown of their recent trades and their value. TipR...